AnalystLens
Stocks
ALNYLAM PHARMACEUTICALS, INC.
Healthcare
Cash Flow
Proceeds from Debt
Search...
⌘K
Stocks
Sectors
Log in
Sign up
Income Statement
Balance Sheet
Cash Flow
Per Share
Back to ALNY
ALNYLAM PHARMACEUTICALS, INC. Proceeds from Debt 2020-2022 | ALNY
Beta
No annual data available.
Proceeds from Debt History
Annual
Quarterly
Period
Value
Change · QoQ
Source
Q2 FY2022
$0
-
10-Q
Q3 FY2021
$0
-100.0%
10-Q
Q2 FY2021
$250.0M
-
10-Q
Q3 FY2020
$0
-
10-Q
Q2 FY2020
$0
-
10-Q
All ALNYLAM PHARMACEUTICALS, INC. (ALNY) Financial Metrics
Income Statement
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
G&A
Total OpEx
Operating Income
Interest Expense
Interest Income
Non-op Income
Pre-tax Income
Income Tax
Net Income
Comprehensive Income
EPS (Basic)
EPS (Diluted)
Balance Sheet
Cash & ST Investments
Total Assets
Current Assets
Cash
Short-Term Investments
Receivables
Inventory
Prepaid & Other
PP&E
Intangibles
Other Non-current
Total Liabilities
Current Liabilities
Accounts Payable
Accrued Liabilities
Deferred Revenue
Long-Term Debt
Other Non-current Liab.
Equity
Retained Earnings
Accumulated OCI
APIC
Total L&E
Shares Outstanding
Cash Flow
Operating Cash Flow
D&A
SBC
Deferred Tax
Investing Cash Flow
CapEx
Free Cash Flow
Financing Cash Flow
Debt Issuance
Debt Repayment
Stock Issuance
Net Change in Cash
Per Share
EPS (Basic)
EPS (Diluted)
Shares Basic
Shares Diluted
Company:
ALNYLAM PHARMACEUTICALS, INC.
Ticker:
ALNY
Sector:
Healthcare
Industry:
Pharmaceutical Preparations
View company profile →